Original title: Directed biosynthesis of the designer peptidyl nucleoside antibiotics featuring a simplified azetidine-containing moiety
Rong Gong, Tianzhu Li, Liwei Zhou, Yuanyuan Liu +8 · September 2026
Dangerous fungal infections are spreading and threaten human and environmental health, creating a strong need for new antifungal medicines. Scientists looked at polyoxin, an environmentally friendly antibiotic that stops fungi from building their protective cell walls. Polyoxin has not been fully explored, so the researchers designed new versions with a simplified, four-membered ring structure called an azetidine ring. They used an industrial polyoxin-producing microbe as a tiny factory to manufacture these custom molecules. Three of the new versions, named POL-AX, POL-HX, and POL-KX, worked better than before against the yeast Candida albicans and a plant pathogen named Phytophthora sojae. Computer models showed that these molecules fit much more snugly into the fungal enzyme that makes cell walls, explaining their boosted power.
You have a key that opens a lock, but it is a bit too big and sometimes jams. You carefully reshape it to be simpler and more streamlined. Now it slides in smoothly every time. In this paper, the researchers simplified the shape of an antifungal molecule so it fits more snugly into the fungal enzyme it targets, boosting its killing power.
Fungal infections harm both people and crops, and resistance is growing. These new antibiotic variants are more potent against two key pathogens, including one that attacks soybeans. Because they are made by modifying an existing industrial process, they could reach farms and clinics faster than entirely new drugs.
The study demonstrates improved activity in vitro and via molecular docking, but does not report in vivo efficacy, toxicity, or resistance development. The analogs were tested against only two pathogens; activity against other fungi is unknown. The directed biosynthesis method may not be easily scalable or applicable to other analogs.
Ask anything about this paper. Answers come from its abstract, and say so when the abstract doesn't cover your question.
Directed biosynthesis of the designer peptidyl nucleoside antibiotics featuring a simplified azetidine-containing moiety — Rong Gong, Tianzhu Li, Liwei Zhou et al. — Synthetic and systems biotechnology — doi:10.1016/j.synbio.2026.08.010
Abstract licence: CC BY
Explanation generated by Synthesis from the abstract — it is not the original paper.